title: [Ergoline-induced retroperitoneal fibrosis].
abstract: A 69-year-old man presented with anaemia, swelling of the legs and scrotum, weight gain and fatigue. MR scan and laboratory findings initiated a search for cancer, but eventually retroperitoneal fibrosis (RF) was suspected. A medical review revealed that an ergoline-based drug known to be associated with RF had been used for eight years. The drug was withdrawn, and in short time the patient substantially recovered, with the disappearance of almost all abnormal findings. This case emphasises the importance of awareness of side effects of drug therapy.
authors.affiliation: Odense Universitetshospital, Medicinsk afdeling C, Reumatologisk Afsnit. lamunk@dadlnet.dk
authors.forename: Lars
authors.initials: L
authors.lastname: Munksgaard
authors.forename: Hanne
authors.initials: H
authors.lastname: Madsen
authors.forename: Pia Birgitte R
authors.initials: PB
authors.lastname: Svolgaard
authors.forename: Jens Møller
authors.initials: JM
authors.lastname: Rasmussen
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010479:Pergolide / Q000009:adverse effects*; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D010479:Pergolide